Moleculin Biotech Q3 EPS $(9.59) Misses $(8.53) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(9.59) per share which missed the analyst consensus estimate of $(8.53) by 12.43 percent. This is a 43.59 percent increase over losses of $(17.00) per share
Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(9.59) per share which missed the analyst consensus estimate of $(8.53) by 12.43 percent. This is a 43.59 percent increase over losses of $(17.00) per share from the same period last year.
